Edwards Lifesciences Total Liabilities and Share Holders Equity 2010-2024 | EW

Edwards Lifesciences total liabilities and share holders equity from 2010 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
  • Edwards Lifesciences total liabilities and share holders equity for the quarter ending September 30, 2024 was $12.971B, a 38.42% increase year-over-year.
  • Edwards Lifesciences total liabilities and share holders equity for 2023 was $9.363B, a 12.91% increase from 2022.
  • Edwards Lifesciences total liabilities and share holders equity for 2022 was $8.293B, a 2.47% decline from 2021.
  • Edwards Lifesciences total liabilities and share holders equity for 2021 was $8.503B, a 17.49% increase from 2020.
Edwards Lifesciences Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2023 $9,363
2022 $8,293
2021 $8,503
2020 $7,237
2019 $6,488
2018 $5,324
2017 $5,666
2016 $4,510
2015 $4,056
2014 $3,523
2013 $2,710
2012 $2,222
2011 $1,981
2010 $1,767
2009 $1,616
Edwards Lifesciences Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-09-30 $12,971
2024-06-30 $10,099
2024-03-31 $9,736
2023-12-31 $9,363
2023-09-30 $9,371
2023-06-30 $9,004
2023-03-31 $8,651
2022-12-31 $8,293
2022-09-30 $8,638
2022-06-30 $8,425
2022-03-31 $8,420
2021-12-31 $8,503
2021-09-30 $8,160
2021-06-30 $7,662
2021-03-31 $7,214
2020-12-31 $7,237
2020-09-30 $6,801
2020-06-30 $6,424
2020-03-31 $6,076
2019-12-31 $6,488
2019-09-30 $5,966
2019-06-30 $5,574
2019-03-31 $5,469
2018-12-31 $5,324
2018-09-30 $5,958
2018-06-30 $5,686
2018-03-31 $5,825
2017-12-31 $5,666
2017-09-30 $5,488
2017-06-30 $5,139
2017-03-31 $4,780
2016-12-31 $4,510
2016-09-30 $4,339
2016-06-30 $4,051
2016-03-31 $3,854
2015-12-31 $4,056
2015-09-30 $3,877
2015-06-30 $3,608
2015-03-31 $3,488
2014-12-31 $3,523
2014-09-30 $3,350
2014-06-30 $3,327
2014-03-31 $2,652
2013-12-31 $2,710
2013-09-30 $2,531
2013-06-30 $2,340
2013-03-31 $2,297
2012-12-31 $2,222
2012-09-30 $2,196
2012-06-30 $2,075
2012-03-31 $2,004
2011-12-31 $1,981
2011-09-30 $1,983
2011-06-30 $2,002
2011-03-31 $1,931
2010-12-31 $1,767
2010-09-30 $1,725
2010-06-30 $1,642
2010-03-31 $1,604
2009-12-31 $1,616
2009-09-30 $1,602
2009-06-30 $1,465
2009-03-31 $1,359
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $43.604B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $197.634B 24.11
Intuitive Surgical (ISRG) United States $186.606B 97.56
Alcon (ALC) Switzerland $41.521B 27.78
IQVIA Holdings (IQV) United States $34.761B 19.15
IDEXX Laboratories (IDXX) United States $33.493B 39.44
DexCom (DXCM) United States $29.615B 44.60
Waters (WAT) United States $21.413B 31.66
STERIS (STE) Ireland $20.170B 23.22
SONOVA HOLDING (SONVY) Switzerland $19.359B 0.00
Hologic (HOLX) United States $16.058B 17.34
Fresenius Medical Care AG KGaA (FMS) Germany $13.192B 13.54
Sysmex ADR (SSMXY) Japan $11.726B 36.77
Globus Medical (GMED) United States $11.158B 28.25
Penumbra (PEN) United States $9.346B 91.55
Masimo (MASI) United States $9.102B 44.04
Teleflex (TFX) United States $8.118B 12.95
Glaukos (GKOS) United States $7.925B 0.00
Integer Holdings (ITGR) United States $4.457B 25.26
PROCEPT BioRobotics (PRCT) United States $4.215B 0.00
Inari Medical (NARI) United States $3.185B 0.00
Veracyte (VCYT) United States $3.028B 90.86
Nihon Kohden (NHNKY) Japan $2.590B 19.67
LivaNova (LIVN) United Kingdom $2.579B 14.89
Tandem Diabetes Care (TNDM) United States $2.185B 0.00
Elekta AB (EKTAY) Sweden $2.096B 18.84
TransMedics (TMDX) United States $2.031B 64.39
Integra LifeSciences Holdings (IART) United States $1.675B 8.75
RxSight (RXST) United States $1.539B 0.00
Alphatec Holdings (ATEC) United States $1.255B 0.00
Artivion (AORT) United States $1.173B 77.69
Pulse Biosciences (PLSE) United States $1.094B 0.00
OPKO Health (OPK) United States $1.072B 0.00
Paragon 28 (FNA) United States $0.820B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.760B 12.92
Mesa Laboratories (MLAB) United States $0.714B 16.83
IRadimed (IRMD) United States $0.676B 36.54
ORTHOFIX MEDICAL INC (OFIX) United States $0.657B 0.00
AxoGen (AXGN) United States $0.654B 0.00
Semler Scientific (SMLR) United States $0.568B 29.92
SiBone (SIBN) United States $0.547B 0.00
OrthoPediatrics (KIDS) United States $0.547B 0.00
Pacific Biosciences Of California (PACB) United States $0.529B 0.00
Treace Medical Concepts (TMCI) United States $0.430B 0.00
Tactile Systems Technology (TCMD) United States $0.407B 22.01
ClearPoint Neuro (CLPT) United States $0.404B 0.00
Delcath Systems (DCTH) United States $0.357B 0.00
AngioDynamics (ANGO) United States $0.349B 0.00
NeuroPace (NPCE) United States $0.333B 0.00
CVRx (CVRX) United States $0.284B 0.00
Alpha Tau Medical (DRTS) Israel $0.219B 0.00
Inogen (INGN) United States $0.198B 0.00
Accuray (ARAY) United States $0.180B 0.00
Sight Sciences (SGHT) United States $0.171B 0.00
KORU Medical Systems (KRMD) United States $0.170B 0.00
Nevro (NVRO) United States $0.135B 0.00
Atossa Genetics (ATOS) United States $0.123B 0.00
Sensus Healthcare (SRTS) United States $0.118B 12.65
Spectral Diagnostics (EDTXF) Canada $0.094B 0.00
LENSAR (LNSR) United States $0.087B 0.00
Monogram Orthopaedics (MGRM) United States $0.086B 0.00
EDAP TMS S.A (EDAP) France $0.081B 0.00
InspireMD (NSPR) Israel $0.078B 0.00
Vicarious Surgical (RBOT) United States $0.071B 0.00
Hyperfine (HYPR) United States $0.068B 0.00
908 Devices (MASS) United States $0.068B 0.00
Covalon Technologies (CVALF) Canada $0.066B 0.00
WORK Medical Technology Group (WOK) China $0.058B 0.00
Lucid Diagnostics (LUCD) United States $0.046B 0.00
EnVVeno Medical (NVNO) United States $0.044B 0.00
Rapid Micro Biosystems (RPID) United States $0.043B 0.00
Neuronetics (STIM) United States $0.039B 0.00
Envoy Medical (COCH) United States $0.037B 0.00
Spectral AI (MDAI) United States $0.035B 0.00
Precision Optics (POCI) United States $0.033B 0.00
NexGel (NXGL) United States $0.031B 0.00
Accelerate Diagnostics (AXDX) United States $0.030B 0.00
Adagio Medical Holdings (ADGM) United States $0.027B 0.00
DarioHealth (DRIO) United States $0.025B 0.00
Biosig Technologies (BSGM) United States $0.022B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
Baird Medical Investment Holdings (BDMD) $0.015B 0.00
Ekso Bionics Holdings (EKSO) United States $0.014B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.008B 0.00
T2 Biosystems (TTOO) United States $0.007B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Tenon Medical (TNON) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.003B 0.00
Check-Cap (CHEK) Israel $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Avinger (AVGR) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00